Your browser doesn't support javascript.
loading
Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding.
Asleh, Rabea; Albitar, Hasan Ahmad Hasan; Schettle, Sarah D; Kushwaha, Sudhir S; Pereira, Naveen L; Behfar, Atta; Stulak, John M; Rodeheffer, Richard J; Iyer, Vivek N.
Afiliação
  • Asleh R; Departments of Cardiovascular Diseases.
  • Albitar HAH; Internal Medicine.
  • Schettle SD; Departments of Cardiovascular Diseases.
  • Kushwaha SS; Departments of Cardiovascular Diseases.
  • Pereira NL; Departments of Cardiovascular Diseases.
  • Behfar A; Departments of Cardiovascular Diseases.
  • Stulak JM; Division of Cardiovascular Surgery.
  • Rodeheffer RJ; Departments of Cardiovascular Diseases.
  • Iyer VN; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: iyer.vivek@mayo.edu.
J Heart Lung Transplant ; 39(5): 492-495, 2020 05.
Article em En | MEDLINE | ID: mdl-32173217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Bevacizumab / Insuficiência Cardíaca / Hemorragia Gastrointestinal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Bevacizumab / Insuficiência Cardíaca / Hemorragia Gastrointestinal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article